ClinicalTrials.Veeva

Menu

Ultrasound Measurement of Quadriceps Shortening During Neuromuscular Electrical Stimulation in Critically Ill Patients (DETECT)

G

Groupe Hospitalier du Havre

Status

Completed

Conditions

Quadriceps Muscle Atrophy
ICU Acquired Weakness

Treatments

Diagnostic Test: Early ultrasound measurement of quadriceps shortening during neuromuscular electrical stimulation (NMES)

Study type

Observational

Funder types

Other

Identifiers

NCT04722445
2020-A01690-39

Details and patient eligibility

About

ICU-Aw is highly prevalent (50%) among critically ill patients. Its diagnosis is usually delayed as it requires patients' awakening and collaboration to provide accurate measurement.

This study aims to investigate the accuracy of an early ultrasound measurement of quadriceps shortening during neuromuscular electrical stimulation to diagnose future ICU-Aw in critically ill patients.

Enrollment

80 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Mechanical ventilation for at least 24 hours

Exclusion criteria

  • Decision to withhold life-sustaining treatment
  • Pregnancy
  • Degenerative neurological pathology with disabling muscle weakness
  • Pace Maker
  • Inability to communicate
  • Chronic loss of autonomy described by the patient's family
  • Guardianship

Trial contacts and locations

1

Loading...

Central trial contact

Yann Combret, PhD, PT

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems